Kodak PCR patent
This article was originally published in The Gray Sheet
Eastman Kodak says it will receive a patent on a method for performing polymerase chain reaction diagnosis. The Kodak method "isolates each test within a disposable reaction enclosure, or 'PCR pouch,' with blister-like compartments containing the necessary chemical reagents for various steps," the company explains. The system "is based on proprietary dyes used in other Kodak test kits, and results are available within a few hours." The method "will significantly widen Kodak's future offerings in in vitro diagnostics," the company says. Kodak recently licensed "key" PCR patients from Roche as part of a patent rights dispute settlement ("The Gray Sheet" June 7, I&W-3).
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.